20/20 HealthCare Partners
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact

20/20 HealthCare Partners

Contact Us

Request Information

    Your Name (required)

    Your Email (required)

    Subject

    Your Message

    20/20 HealthCare Partners
    2000 Commonwealth Ave
    Suite 200
    Auburndale, MA 02466

    Latest News

    • Variantyx Secures $20M Debt Financing to Support Precision Medicine in North America, Europe October 18, 2022
    • SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting June 21, 2022
    • SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors April 28, 2022
    • SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo April 11, 2022
    • SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes April 5, 2022

    20/20 HealthCare Partners | 2000 Commonwealth Ave, Suite 200, Auburndale, MA 02466 | Contact Us

    Copyright © 2019
    • Home
    • What Differentiates 20/20 HCP
    • Team
    • Companies
      • Companies
      • Exits
    • News
    • Contact